Back to Results

CV Sciences Inc (CVSI)

CV Sciences, Inc. is a common stock listing on OTC Markets for the company of the same name. The San Diego-based business develops, manufactures, markets, and sells herbal supplements, hemp-derived cannabidiol (CBD), and plant-based food products in North America. Its product portfolio is sold under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brands, with distribution spanning the company’s websites, selected distributors, brick-and-mortar retailers, and e-tailers. CV Sciences serves health care-related categories including nutraceuticals, beauty care, specialty foods, and pet products. The company was incorporated in 2010 and adopted its current name in January 2016 after previously operating as CannaVest Corp.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-CVSI
$0.019
24.7% Upside
Undervalued
Not available
Not available
Weak
0.0%
November 16, 2026
2.0x
0.2x
3.387 M
4.149 M
28.4%
81.2%
-20.8
26.0%
Valuation • Fair Value

CV Sciences Inc (OTC-CVSI) Fair Value by Valuation Model

Review the available estimates for CV Sciences Inc (OTC-CVSI), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.019

Estimated upside of 24.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.019

Discounted cash flow valuation reference.

Comps Fair Value

$0.019

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for CV Sciences Inc (OTC-CVSI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for CV Sciences Inc (OTC-CVSI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

12.743 M

Current operating scale indicator.

Revenue Forecast

13.789 M

Forward revenue estimate.

EBITDA

-872 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review CV Sciences Inc (OTC-CVSI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for CV Sciences Inc (OTC-CVSI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.80

No elevated caution signal from this screen.

Altman Z-Score

-20.8

Lower score that deserves closer risk review.

FCF / Net Income

26.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for CV Sciences Inc (OTC-CVSI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for CV Sciences Inc (OTC-CVSI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 16, 2026

Days to Earnings

55

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for CV Sciences Inc (OTC-CVSI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

CV Sciences Inc (OTC-CVSI) Stock Forecast & Technical Outlook

Review CV Sciences Inc (OTC-CVSI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for CV Sciences Inc (OTC-CVSI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for CV Sciences Inc (OTC-CVSI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for CV Sciences Inc (OTC-CVSI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, CV Sciences Inc (OTC-CVSI) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

CV Sciences Inc (OTC-CVSI) Stock FAQ

Data-supported answers about CV Sciences Inc (OTC-CVSI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.019
Estimated upside 24.7%
Valuation Rating
Undervalued
Estimated upside of 24.7%
Financial Health
Weak
Current financial-health read

The current fair value estimate for CV Sciences Inc (OTC-CVSI) is $0.019. This implies an estimated upside of 24.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 24.7% versus the current market price.

The current financial health read for CV Sciences Inc (OTC-CVSI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for CV Sciences Inc (OTC-CVSI) is November 16, 2026.

The latest available data indicates no current dividend yield for CV Sciences Inc (OTC-CVSI).

The current market capitalization listed for CV Sciences Inc is 3.387 M.

The current enterprise value listed for CV Sciences Inc is 4.149 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for CV Sciences Inc is OTC-CVSI, and the stock is listed on OTC Markets.

CV Sciences Inc (OTC-CVSI) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for CV Sciences Inc is 28.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for CV Sciences Inc is 81.2%. Free float helps investors understand how much of the share base is available for public trading.

Similar Personal Care Products Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

UL NYSE Unilever PLC ADR Fair Value Fair Market Cap 135 B
EL NYSE Estee Lauder Companies Inc Fair Value Fair Market Cap 36.285 B
KVUE NYSE Kenvue Inc Fair Value Fair Market Cap 34.305 B
ELF NYSE ELF Beauty Inc Fair Value Fair Market Cap 6.026 B
IPAR NASDAQ Inter Parfums Inc Fair Value Fair Market Cap 3.788 B
COTY NYSE Coty Inc Fair Value Undervalued Market Cap 2.351 B
EPC NYSE Edgewell Personal Care Co Fair Value Undervalued Market Cap 1.289 B
HLF NYSE Herbalife Nutrition Ltd Fair Value Fair Market Cap 1.282 B
BRBR NYSE Bellring Brands LLC Fair Value Bargain Market Cap 1.045 B
ODD NASDAQ Oddity Tech Ltd Fair Value Fair Market Cap 866.2 M
HNST NASDAQ Honest Company Inc Fair Value Overvalued Market Cap 580.4 M
USNA NYSE USANA Health Sciences Inc Fair Value Undervalued Market Cap 273.1 M
YSG NYSE Yatsen Holding Fair Value Undervalued Market Cap 256.1 M
NAGE NASDAQ Niagen Bioscience Inc Fair Value Undervalued Market Cap 245 M
NUS NYSE Nu Skin Enterprises Inc Fair Value Undervalued Market Cap 236.6 M
NATR NASDAQ Natures Sunshine Products Inc Fair Value Undervalued Market Cap 232.6 M
MED NYSE MEDIFAST INC Fair Value Undervalued Market Cap 124.9 M
UPXI NASDAQ Upexi Inc Fair Value Overvalued Market Cap 102.6 M
SKIN NASDAQ Skinhealth Systems Inc Fair Value Undervalued Market Cap 87.611 M
FTLF NASDAQ FitLife Brands Inc Fair Value Undervalued Market Cap 87.431 M